Your browser doesn't support javascript.
Complete persistent remission of rheumatoid arthritis after COVID-19 infection - A rare case and literature review.
Barman, Bhupen; Nune, Arvind; Ish, Pranav; Phukan, Pranjal; Lynser, Donboklang; Sapkota, Hem Raj.
  • Barman B; Department of General Medicine, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong. drbhupenb@gmail.com.
  • Nune A; Department of Rheumatology, Southport and Ormskirk NHS Trust, Southport. arvind.nune@nhs.net.
  • Ish P; Department of Pulmonary and Critical Care Medicine, Safdarjung Hospital and Vardhman Mahavir Medical College, New Delhi. pranavish2512@gmail.com.
  • Phukan P; Department of Radiology and Imaging, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong. pphukan10@gmail.com.
  • Lynser D; Department of Radiology and Imaging, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong. bokdlynser@yahoo.co.in.
  • Sapkota HR; Department of Rheumatology, The Royal Wolverhampton NHS Trust, Wolverhampton. hem.sapkota@nhs.net.
Monaldi Arch Chest Dis ; 2022 Jun 08.
Article in English | MEDLINE | ID: covidwho-2251292
ABSTRACT
A 55-year-old man was admitted to a hospital in Northeast India with fever, cough and breathlessness and was diagnosed with severe COVID-19 pneumonia. He was a known case of seropositive, erosive rheumatoid arthritis (RA) and was taking disease-modifying anti-rheumatic drugs (DMARDs). The patient was treated with remdesivir, heparin and a short course of corticosteroids for COVID-19 pneumonia. With the improvement of COVID-19 pneumonia, the patient also noticed a marked improvement in his joint symptoms despite not taking any DMARDs for RA. The temporal relationship between the time of disappearance of all signs and symptoms of RA within a few days after COVID-19 pneumonia and maintenance of RA remission for over one year of follow up to date suggests that COVID-19 likely caused the remission of RA. This case highlights the need for larger studies to understand the COVID-19 effects on RA remission and their potential link if any. However, the evidence of worse outcome with COVID-19 in immunosuppression which is common in RA cannot be overlooked.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Prognostic study / Reviews Topics: Long Covid Language: English Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Prognostic study / Reviews Topics: Long Covid Language: English Year: 2022 Document Type: Article